Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...
People taking popular new weight-loss drugs such as Wegovy and Zepbound often celebrate the number of pounds they shed and the related health benefits, but many doctors at weight-loss clinics are ...
Janet McCaskill was on vacation in Arizona with her husband and best friend when she heard that President Donald Trump had suggested he might be able to bring the cost of popular weight-loss drugs ...
Everyday Health on MSN
GLP-1 Drugs Like Ozempic May Boost Colon Cancer SurvivalPeople with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study ...
Hosted on MSN
New study: Ozempic and Wegovy protect the HeartA major international study led by researchers at University College London has found that semaglutide, the active ingredient in Ozempic and Wegovy, may protect the heart even when users lose little ...
GLP-1 drugs like semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, were originally intended to treat diabetes — and didn’t become blockbuster prescriptions until doctors ...
Weight-loss surgery dramatically outperformed GLP-1 medications in improving longevity and reducing heart, kidney, and eye complications for people with obesity and diabetes. Over 10 years, patients ...
The obesity rate for adults in the U.S. dropped to 37% in 2025 after peaking at 39.9% in 2022, but diabetes has reached an all-time high, at 13.8%, according to a Gallup survey. Over a 10-year span, ...
Listen to more stories on the Noa app. Sign up for Being Human, our newsletter that explores wellness culture, human behavior, mortality and disease, and other mysteries of the body and the mind. An ...
Dr. Troy Mensen is a family medicine doctor based in the Chicago area. He completed his undergraduate degree at the University of Northern Iowa and his doctorate at Des Moines University College of ...
The U.S. Food and Drug Administration says no link between Tylenol use during pregnancy and autism has been proven Kenvue and Johnson & Johnson called the lawsuit 'baseless' WEDNESDAY, Oct. 29, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback